ANTIMICROBIAL DRUG-USE IN HOSPITALS IN THE NETHERLANDS, GERMANY AND BELGIUM

被引:41
作者
JANKNEGT, R
WIJNANDS, WJA
CAPRASSE, M
BRANDENBURG, W
SCHUITENMAKER, MG
STOBBERINGH, E
机构
[1] STICHTING DEVENTER ZIEKENHUIZEN, DEPT PULMONOL, 7400 GC DEVENTER, NETHERLANDS
[2] CHU LIEGE, SERV PHARM, B-4000 LIEGE, BELGIUM
[3] RHEIN WESTFAL TH AACHEN KLINIKUM, DEPT CLIN PHARM, D-52074 AACHEN, GERMANY
[4] ZIEKENHUIS HEEL, DEPT CLIN PHARM, 1500 EE ZAANDAM, NETHERLANDS
[5] ACAD ZIEKENHUIS MAASTRICHT, DEPT MED MICROBIOL, 6202 AZ MAASTRICHT, NETHERLANDS
关键词
D O I
10.1007/BF02000403
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Data on the use of antimicrobial drugs was collected by means of an inquiry to 30 hospitals in Belgium (15 in Dutch sectors and 15 in the French sectors), 21 hospitals in Germany and 20 hospitals in the Netherlands. The use of these drugs was expressed as the number of defined daily doses (DDD) per 100 bed days by the anatomical therapeutical chemical classification system. The total use of antimicrobial agents was significantly (p < 0.001) higher in both parts of Belgium (55.6 and 52.0 DDD per 100 bed days) than in Germany (37.9 DDD) or the Netherlands (34.1 DDD). In particular, amoxicillin-clavulanic acid, the first- and second-generation cephalosporins, aminoglycosides and fluoroquinolones were used more in Belgium than in either of the other countries. At least part of the differences observed in antimicrobial drug use could be explained by differences in written antibiotic policy.
引用
收藏
页码:832 / 838
页数:7
相关论文
共 15 条
[1]  
Buirma R J, 1991, Scand J Infect Dis Suppl, V78, P35
[2]  
DESMET PAG, 1990, MEDICATIEBEGELEIDING, P449
[3]  
HEKSTER Y A, 1987, Journal de Pharmacie Clinique, V6, P335
[4]  
HEKSTER YA, 1983, SELECTION CRITERIA A
[5]  
JANKNEGT R, 1992, VERBRUIKSGEGEVENS ZI, V8, P96
[6]   RESISTANCE OF GRAM-NEGATIVE BACILLI AS RELATED TO HOSPITAL USE OF ANTI-MICROBIAL AGENTS [J].
MA, MY ;
GOLDSTEIN, EJC ;
FRIEDMAN, MH ;
ANDERSON, MS ;
MULLIGAN, ME .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :347-352
[7]  
MARTINI N, 1990, PROGR CLIN PHARM, P220
[8]  
NEU HC, 1992, DIAGN MICR INFEC DIS, V15, pS53
[9]  
NEU HC, 1992, DIAGN MICR INFEC DIS, V15, pS49
[10]  
Payer L., 1988, MED CULTURE, P204